« Tip of the ... Iceberg? | Main | Tshabalala´s remedy: "Garlic, lemon and African potato" »
September 19, 2006
The new business model...positioning for a sell
by Kelly McKenna
Biotech and biopharma companies are increasingly looking to sell. While, in the past, these early to mid-stage companies wanted to do it themselves - commercializing and marketing their product, going public, building their pipeline and maturing into a Genentech or Amgen. With Wall Street less inviting, they're now exploring more lucrative alternatives to IPOs. Reflecting this trend, there were more IPOs in European biotech last year than U.S. biotech. Granted this was also a factor of globalization of the field and a conservative U.S. investment market.
As PR professionals, we need to: 1) help our clients position themselves favorably to potential buyers, an audience now just as important as investors, and 2) prepare and protect ourselves from erosion through ongoing mergers and acquisitions. This is particularly an issue in California, where hundreds of biotech start-ups pop up every year.
Posted by kelly_mckenna at September 19, 2006 11:37 AM
Trackback Pings
TrackBack URL for this entry:
/cgi-bin/mt-tb.cgi/34
